Colorectal Adenocarcinoma Clinical Trials

116 clinical trials for Colorectal Adenocarcinoma across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Family Communications After Genetic Testing — RECRUITING · NA
• A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis — RECRUITING · NA
• A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors — RECRUITING · PHASE1
• Early Detection of Advanced Adenomas and Colorectal Cancer — RECRUITING
• Stage II/III Colorectal Cancer Recurrence — RECRUITING
• Early Onset Colorectal Cancer Detection — RECRUITING
• Evaluation of Skin Tests in Biotherapy Allergies — RECRUITING · NA
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study — RECRUITING
• Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas — RECRUITING · PHASE1
• Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer — RECRUITING · PHASE1
• Measurement of MMP-14 Protein, a Potential New Marker for Colorectal Cancer Detection, in Plasma Vesicles Named Exosomes — RECRUITING · NA
• AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer — RECRUITING · PHASE3
• Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer. — RECRUITING · PHASE2
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation — RECRUITING · PHASE1
• DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies — RECRUITING
• Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II) — RECRUITING · NA
• A PHASE III STUDY OF BOTENSILIMAB + BALSTILIMAB VERSUS BEST SUPPORTIVE CARE IN CHEMO-REFRACTORY UNRESECTABLE COLORECTAL ADENOCARCINOMA: THE BATTMAN TRIAL — RECRUITING · PHASE3
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• AK129 Combination Therapy for Advanced Solid Tumors — RECRUITING · PHASE1
• Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. — RECRUITING · PHASE2
• A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. — RECRUITING · NA
• Factors Affecting the Results of Treatment of Patients With Colorectal Cancer — RECRUITING
• A PHASE II STUDY OF PERIOPERATIVE QBECO SITE SPECIFIC IMMUNOMODULATOR (QU BIOLOGICS®) IN PATIENTS WITH METASTATIC COLORECTAL ADENOCARCINOMA WITHIN THE LIVER UNDERGOING RESECTION — RECRUITING · PHASE2
• A PHASE III, OPEN-LABEL, MULTICENTER, THREE-ARM, RANDOMIZED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF COBIMETINIB PLUS ATEZOLIZUMAB AND ATEZOLIZUMAB MONOTHERAPY VS. REGORAFENIB IN PATIENTS WITH PREVIOUSLY TREATED UNRESECTABLE LOCALLY ADVANCED OR METASTATIC COLORECTAL ADENOCARCINOMA — RECRUITING · PHASE3
• Breath Research Narrow Validation for Gastrointestinal Cancer Detection — NOT_YET_RECRUITING
• A phase I/IIa safety, dose finding and feasibility trial of CD30/CEA CART in patients with liver metastases from CEA positive colorectal adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal Cancer — NOT_YET_RECRUITING · PHASE2
• TLR9 Immunotherapy for Peritoneal Carcinomatosis — NOT_YET_RECRUITING · PHASE1
• Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer — COMPLETED · PHASE2
• Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer — COMPLETED · PHASE1
• Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial — NOT_YET_RECRUITING · PHASE2
• A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer — SUSPENDED · PHASE1
• PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer — COMPLETED · PHASE1
• Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study — TERMINATED · NA
• Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients — COMPLETED · PHASE1
• Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Study Comparing the Quality of Colon Cleanliness With Prepackaged LRD (Low-residue Diet) vs. Guided (POG). — NOT_YET_RECRUITING · NA
• Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver — COMPLETED · PHASE2
• METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin — ACTIVE_NOT_RECRUITING · PHASE2
• A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• BEvacizumab plus Trifluridine/tipiracil in a bi-WEEkly administration to reduce grade 3-4 Neutropenia in patients with mCRC: A prospective, multicenter, comparative, randomized GERCOR G-124 BETWEEN phase II study — TERMINATED · PHASE2
• A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer — TERMINATED · PHASE2
• A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Phase 2 Study of DKN-01 in Colorectal Cancer — COMPLETED · PHASE2
• Predicting Local and Distant Recurrence in T1 Colorectal Cancer — COMPLETED
• Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer — COMPLETED · PHASE2

Refine this search